Position in AXSM
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$117,994,070
+$20,388,570 QoQ
Shares Held
482,061
-16.5% QoQ
Ownership
0.920%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#19
of 494 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. AXSM ranks #8 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
This page
|
482,061 | $117,994,070 |
All Filings in AXSM
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $117,994,070 | 482,061 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $97,605,500 | 577,479 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,928,950 | 43,413 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,510,288 | 37,137 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $6,488,882 | 62,160 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,376,555 | 28,951 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,618,013 | 54,580 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,872,678 | 43,092 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,140,575 | 26,591 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,227,857 | 65,512 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,564,057 | 69,909 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||